Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors.
Abdulmalik S AlotaibiPharmaceutical Practices Department, College of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia.ORCID 0000-0002-4336-1901
Mohamed A AlbekeryDepartment of Pharmacy Practice, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0001-8472-3043
Ahmed A AlanaziDepartment of Pharmacy Practice, College of Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia.ORCID 0009-0006-3611-0529
Ibrahim S AlhomoudDepartment of Pharmacy Practice, College of Pharmacy, Qassim University, Qassim 51452, Saudi Arabia.ORCID 0009-0000-3346-1223
Khalid A AlamerDepartment of Pharmacy Practice, College of Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia.
Mohammad ShawaqfehCollege of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi Arabia.ORCID 0000-0003-0469-2764
Reem H AlshammariCollege of Pharmacy, Northern Border University, Arar 73213, Saudi Arabia.
Fayez AlhejailiCollege of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi Arabia.ORCID 0009-0003-3516-2499
Muthana Al SahlawiDepartment of Internal Medicine, College of Medicine, King Faisal University, Hofuf 31982, Saudi Arabia.ORCID 0000-0002-2056-7165
Ibrahim AldossaryPharmaceutical Care Services, King Abdulaziz Hospital, Ministry of National Guard Health Affairs, Hofuf 31982, Saudi Arabia.
Hajar Adel AljuaylDepartment of Pharmacy Practice, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0009-0001-8826-3627
Mohammad AlkathiriCollege of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi Arabia.
Shmeylan AlharbiCollege of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi Arabia.
Abdulkareem AlbekairyCollege of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi Arabia.
Abdulmalik AlkatheriCollege of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi Arabia.
Funding
Umm AI-Qura University, Saudi Arabia 25UQU4420027GSSR01
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Evaluation of Statins Use in Hemodialysis Patients: A Retrospective Analysis of Clinical and Safety Outcomes. · full record | Socratic